Bone Marrow TransplantationBone MarrowTissue DonorsBone Marrow CellsHistocompatibility TestingTransplantation, HomologousHistocompatibilityGraft vs Host DiseaseBone and BonesTransplantation ChimeraHLA AntigensTissue and Organ ProcurementGraft SurvivalAnemia, AplasticWhole-Body IrradiationLeukemiaHematopoietic Stem CellsTransplantation ConditioningHematopoietic Stem Cell TransplantationGraft RejectionBone RemodelingBone Marrow DiseasesBone Marrow ExaminationImmunosuppressionRadiation ChimeraBone Marrow NeoplasmsTransplantation, AutologousMice, Inbred C57BLLeukocyte TransfusionRegistriesImmunosuppressive AgentsGraft Enhancement, ImmunologicLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsTransplantation ToleranceBone Marrow PurgingBone DensityTreatment OutcomeRecurrenceHematologic NeoplasmsTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaHematopoiesisT-LymphocytesBone ResorptionLiving DonorsCytomegalovirus InfectionsAcute DiseaseSkin TransplantationBlood DonorsLymphocyte DepletionKidney TransplantationChimerismSurvival AnalysisGraft vs Host ReactionLeukemia, Myeloid, AcuteColony-Forming Units AssayActuarial AnalysisLymphocyte Culture Test, MixedBone NeoplasmsCell DifferentiationMice, Inbred BALB CRetrospective StudiesImmunocompromised HostOpportunistic InfectionsBone DevelopmentDisease-Free SurvivalBone DiseasesTransplantation ImmunologyFlow CytometryBusulfanCells, CulturedCyclosporineHeart TransplantationChimeraCyclophosphamideMyelodysplastic SyndromesHematologic DiseasesMycosesLeukemia, MyeloidBone RegenerationFatal OutcomeMice, Inbred C3HSpleenAntigens, CD34CytomegalovirusLymphocyte TransfusionGranulocytesCombined Modality TherapyStromal CellsMultiple MyelomaNuclear FamilySurvival RateOsteogenesisLeukocyte CountPolymerase Chain ReactionPneumonia, ViralImmune ToleranceBone MatrixCell Separation